Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 36.93 USD -5.31% Market Closed
Market Cap: 3B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Wall Street
Price Targets

VRNA Price Targets Summary
Verona Pharma PLC

Wall Street analysts forecast VRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRNA is 39.08 USD with a low forecast of 31.82 USD and a high forecast of 52.5 USD.

Lowest
Price Target
31.82 USD
14% Downside
Average
Price Target
39.08 USD
6% Upside
Highest
Price Target
52.5 USD
42% Upside

VRNA Last Price Targets
Verona Pharma PLC

The latest public price target was made on Nov 5, 2024 by Raghuram Selvaraju from H.C. Wainwright , who expects VRNA stock to rise by 14% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Raghuram Selvaraju
H.C. Wainwright
42 USD
Upside 14%
1 week ago
Nov 5, 2024
Verona Pharma (VRNA) PT Raised to $42 at H.C. Wainwright
StreetInsider
Edward Nash
Canaccord Genuity
37 USD
Upside 0%
3 months ago
Jul 22, 2024
Verona Pharma (VRNA) PT Raised to $37 at Canaccord Genuity
StreetInsider
Raghuram Selvaraju
H.C. Wainwright
36 USD
Downside 3%
4 months ago
Jun 27, 2024
Verona Pharma price target raised to $36 from $32 at H.C. Wainwright
TheFly
Andrew Tsai
Jefferies
38 USD
Upside 3%
5 months ago
May 28, 2024
Expert likely to prescribe more ensifentrine than dupixent, says Jefferies
TheFly
Yasmeen Rahimi
Piper Sandler
36 USD
Downside 3%
6 months ago
Apr 16, 2024
Verona Pharma (VRNA) PT Raised to $36 at Piper Sandler
StreetInsider
Raghuram Selvaraju
H.C. Wainwright
Price Target 42 USD
Upside/Downside 14%
View Source
Edward Nash
Canaccord Genuity
Price Target 37 USD
Upside/Downside 0%
View Source
Raghuram Selvaraju
H.C. Wainwright
Price Target 36 USD
Upside/Downside 3%
View Source
Andrew Tsai
Jefferies
Price Target 38 USD
Upside/Downside 3%
View Source
Yasmeen Rahimi
Piper Sandler
Price Target 36 USD
Upside/Downside 3%
View Source
Verona Pharma PLC Competitors:
Price Targets
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
EAPI
Euroapi SAS
6% Downside
BSEM
Biostem Technologies Inc
6% Upside
605507
Guobang Pharma Ltd
16% Upside
ALM
Almirall SA
41% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
6% Upside
DERM
Journey Medical Corp
82% Upside
NEULANDLAB
Neuland Laboratories Ltd
18% Downside

Revenue
Forecast

Revenue Estimate
Verona Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Verona Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Verona Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRNA's stock price target?
Price Target
39.08 USD

According to Wall Street analysts, the average 1-year price target for VRNA is 39.08 USD with a low forecast of 31.82 USD and a high forecast of 52.5 USD.

Back to Top